Movement Alert｜METiS Pharmaceuticals-P Declines 5.49% in Regular Trading, Over-Allotment Shares Officially Listed Adding Selling Pressure

Market Focus06-10

On June 10, METiS Pharmaceuticals-P (07666.HK) fell 5.49% in regular trading, trading at HKD 12.27 per share, with trading volume of HKD 11.29 million. The stock has been in a sustained pullback since surging 173% on its listing debut on May 13.

On the news front, the company previously announced that the over-allotment option was fully exercised on June 5, involving 30.184 million H shares issued at the IPO price of HKD 10.50 per share. These over-allotment shares officially commenced trading on the Hong Kong Stock Exchange on June 10, directly increasing circulating supply and intensifying market selling pressure.

Meanwhile, the price stabilization period ended on June 7, meaning the mechanism that had previously supported the stock price has formally exited. Combined with the fact that certain international placement shares carry no lock-up period, profit-taking pressure continues to be released. These multiple factors have compounded to sustain the downward trajectory for the AI-driven drug delivery company since its post-IPO peak.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133103618?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 10:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133103618","market":"hk","top_or_hot":-1,"title":"Movement Alert｜METiS Pharmaceuticals-P Declines 5.49% in Regular Trading, Over-Allotment Shares Officially Listed Adding Selling Pressure","media":"Market Focus","content":"<p><p>On June 10, METiS Pharmaceuticals-P (07666.HK) fell 5.49% in regular trading, trading at HKD 12.27 per share, with trading volume of HKD 11.29 million. The stock has been in a sustained pullback since surging 173% on its listing debut on May 13.</p><p>On the news front, the company previously announced that the over-allotment option was fully exercised on June 5, involving 30.184 million H shares issued at the IPO price of HKD 10.50 per share. These over-allotment shares officially commenced trading on the Hong Kong Stock Exchange on June 10, directly increasing circulating supply and intensifying market selling pressure.</p><p>Meanwhile, the price stabilization period ended on June 7, meaning the mechanism that had previously supported the stock price has formally exited. Combined with the fact that certain international placement shares carry no lock-up period, profit-taking pressure continues to be released. These multiple factors have compounded to sustain the downward trajectory for the AI-driven drug delivery company since its post-IPO peak.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜METiS Pharmaceuticals-P Declines 5.49% in Regular Trading, Over-Allotment Shares Officially Listed Adding Selling Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜METiS Pharmaceuticals-P Declines 5.49% in Regular Trading, Over-Allotment Shares Officially Listed Adding Selling Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-10 10:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 10, METiS Pharmaceuticals-P (07666.HK) fell 5.49% in regular trading, trading at HKD 12.27 per share, with trading volume of HKD 11.29 million. The stock has been in a sustained pullback since surging 173% on its listing debut on May 13.</p><p>On the news front, the company previously announced that the over-allotment option was fully exercised on June 5, involving 30.184 million H shares issued at the IPO price of HKD 10.50 per share. These over-allotment shares officially commenced trading on the Hong Kong Stock Exchange on June 10, directly increasing circulating supply and intensifying market selling pressure.</p><p>Meanwhile, the price stabilization period ended on June 7, meaning the mechanism that had previously supported the stock price has formally exited. Combined with the fact that certain international placement shares carry no lock-up period, profit-taking pressure continues to be released. These multiple factors have compounded to sustain the downward trajectory for the AI-driven drug delivery company since its post-IPO peak.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1133103618","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133103618","pubTimestamp":1781058875,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 10, METiS Pharmaceuticals-P (07666.HK) fell 5.49% in regular trading, trading at HKD 12.27 per share, with trading volume of HKD 11.29 million. The stock has been in a sustained pullback...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"动向提示|METiS Pharmaceuticals-P常规交易下跌5.49%超额配售股正式上市增添抛压","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"On June 10, METiS Pharmaceuticals-P (07666.HK) fell 5.49% in regular trading, trading at HKD 12.27 per share, with trading volume of HKD 11.29 million. The stock has been in a sustained pullback since surging 173% on its listing debut on May 13.On the news front, the company previously announced that the over-allotment option was fully exercised on June 5, involving 30.184 million H shares issued at the IPO price of HKD 10.50 per share. These over-allotment shares officially commenced trading on the Hong Kong Stock Exchange on June 10, directly increasing circulating supply and intensifying market selling pressure.Meanwhile, the price stabilization period ended on June 7, meaning the mechanism that had previously supported the stock price has formally exited. Combined with the fact that certain international placement shares carry no lock-up period, profit-taking pressure continues to be released. These multiple factors have compounded to sustain the downward trajectory for the AI-driven drug delivery company since its post-IPO peak.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133103618","isCrawlerRequest":true}